Tower Research Capital (TRC)’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.66K Sell
2,002
-7,359
-79% -$9.79K ﹤0.01% 4611
2025
Q1
$11.1K Buy
9,361
+4,306
+85% +$5.12K ﹤0.01% 3568
2024
Q4
$8.24K Buy
5,055
+2,284
+82% +$3.72K ﹤0.01% 4005
2024
Q3
$10.6K Sell
2,771
-12,174
-81% -$46.5K ﹤0.01% 3739
2024
Q2
$43.8K Buy
14,945
+10,792
+260% +$31.6K ﹤0.01% 3200
2024
Q1
$16.4K Sell
4,153
-4,893
-54% -$19.4K ﹤0.01% 3181
2023
Q4
$45K Buy
9,046
+7,612
+531% +$37.8K ﹤0.01% 3203
2023
Q3
$7.24K Sell
1,434
-1,168
-45% -$5.9K ﹤0.01% 4490
2023
Q2
$13.1K Buy
2,602
+834
+47% +$4.2K ﹤0.01% 3781
2023
Q1
$11K Sell
1,768
-506
-22% -$3.15K ﹤0.01% 4248
2022
Q4
$30K Sell
2,274
-11,717
-84% -$155K ﹤0.01% 2749
2022
Q3
$42K Buy
+13,991
New +$42K ﹤0.01% 3320
2022
Q2
Sell
-124
Closed -$1K 6414
2022
Q1
$1K Sell
124
-9,797
-99% -$79K ﹤0.01% 5833
2021
Q4
$80K Sell
9,921
-8,076
-45% -$65.1K ﹤0.01% 2384
2021
Q3
$269K Buy
17,997
+14,806
+464% +$221K 0.01% 1520
2021
Q2
$40K Sell
3,191
-20,256
-86% -$254K ﹤0.01% 3213
2021
Q1
$107K Buy
+23,447
New +$107K ﹤0.01% 2540
2020
Q4
Sell
-2,717
Closed -$6K 5343
2020
Q3
$6K Buy
+2,717
New +$6K ﹤0.01% 4301
2019
Q2
Sell
-370
Closed -$3K 4128
2019
Q1
$3K Buy
+370
New +$3K ﹤0.01% 3309
2018
Q3
Sell
-128
Closed -$3K 4133
2018
Q2
$3K Buy
+128
New +$3K ﹤0.01% 3245
2018
Q1
Sell
-169
Closed -$31K 3731
2017
Q4
$31K Buy
169
+23
+16% +$4.22K ﹤0.01% 1715
2017
Q3
$32K Buy
146
+86
+143% +$18.8K ﹤0.01% 2385
2017
Q2
$12K Buy
+60
New +$12K ﹤0.01% 1516
2017
Q1
Sell
-3
Closed -$1K 3699
2016
Q4
$1K Sell
3
-96
-97% -$32K ﹤0.01% 3640
2016
Q3
$21K Buy
+99
New +$21K ﹤0.01% 1585
2016
Q1
Sell
-26
Closed -$6K 4717
2015
Q4
$6K Buy
+26
New +$6K ﹤0.01% 2800